Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-[5-(trifluoromethyl)-4H-1,2,4-triazol-3-yl] 5-(phenylethynyl)furan-2-carbothioate is a synthetic small molecule compound that belongs to several chemical classes including furans, triazoles, organofluorine compounds (due to the trifluoromethyl group), thioesters (carbothioate), and acetylenic compounds (due to the phenylethynyl moiety)[1][6][8]. It is listed as an experimental pharmaceutical in chemical databases but has no approved medical indications or known clinical development. Its mechanism of action and biological targets are not described in public drug databases. The compound appears primarily in research contexts and chemical libraries[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-[5-(trifluoromethyl)-4H-1,2,4-triazol-3-yl] 5-(phenylethynyl)furan-2-carbothioate.